» Articles » PMID: 15289006

The Somatodendritic Release of Dopamine in the Ventral Tegmental Area and Its Regulation by Afferent Transmitter Systems

Overview
Date 2004 Aug 4
PMID 15289006
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

The release of dopamine in the ventral tegmental area (VTA) plays an important role in the autoinhibition of the dopamine neurons of the mesocorticolimbic system through the activation of somatodendritic dopamine D2 autoreceptors. Accordingly, the intra-VTA application of dopamine D2 receptor agonists reduces the firing rate and release of dopamine in the VTA, and this control appears to possess a tonic nature because the corresponding antagonists enhance the somatodendritic release of the transmitter. In addition, the release of dopamine in the VTA is increased by potassium or veratridine depolarization and abolished by tetrodotoxin and calcium omission. Overall, it appears that the somatodendritic release of dopamine is consistently lower than that in nerve endings. Apart from intrinsic dopaminergic mechanisms, other transmitter systems such as serotonin, noradrenaline, acetylcholine, GABA and glutamate play a role in the control of the activity of dopaminergic neurons of the VTA, although the final action depends on the particular receptor involved as well as the neuronal type where it is localized. Given the involvement of the mesocorticolimbic dopaminergic systems in the pathogenesis of severe neuropsychiatric disorders such as schizophrenia, the knowledge of the factors that regulate the release of dopamine in the VTA could provide new insight into the ethiogenesis of the disease as well as its implication on the mechanisms of action of therapeutic drugs.

Citing Articles

Regulator of G protein signaling 6 (RGS6) in dopamine neurons promotes EtOH seeking, behavioral reward, and susceptibility to relapse.

Spicer M, Weber M, Luo Z, Yang J, Narayanan N, Fisher R Psychopharmacology (Berl). 2024; 241(11):2255-2269.

PMID: 38856764 PMC: 11518640. DOI: 10.1007/s00213-024-06631-8.


Physical Exercise Promotes Beneficial Changes on Neurotrophic Factors in Mesolimbic Brain Areas After AMPH Relapse: Involvement of the Endogenous Opioid System.

H Z R, H J S, R C S B, Kr R, R R, M E B Neurotox Res. 2023; 41(6):741-751.

PMID: 37904065 DOI: 10.1007/s12640-023-00675-y.


The rostromedial tegmental nucleus RMTg is not a critical site for ethanol-induced motor activation in rats.

Esposito-Zapero C, Fernandez-Rodriguez S, Sanchez-Catalan M, Zornoza T, Cano-Cebrian M, Granero L Psychopharmacology (Berl). 2023; 240(10):2071-2080.

PMID: 37474756 PMC: 10506920. DOI: 10.1007/s00213-023-06425-4.


Metabolic hormone action in the VTA: Reward-directed behavior and mechanistic insights.

Geisler C, Hayes M Physiol Behav. 2023; 268:114236.

PMID: 37178855 PMC: 10330780. DOI: 10.1016/j.physbeh.2023.114236.


Degeneracy and stability in neural circuits of dopamine and serotonin neuromodulators: A theoretical consideration.

Behera C, Joshi A, Wang D, Sharp T, Wong-Lin K Front Comput Neurosci. 2023; 16:950489.

PMID: 36761394 PMC: 9905743. DOI: 10.3389/fncom.2022.950489.